Shanghai Fosun Pharmaceutical (group) Co., Ltd. Class ASSE: 600196

Announcement on Holding Subsidiary’s Drug Obtaining Approval for Clinical Trial

· Issued by Shanghai Fosun Pharmaceutical (group) Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on Holding Subsidiary’s Drug Obtaining Approval for Clinical Trial

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment